Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Armstrong World Industries
AWI
$7.38B
| $56.6M | 0.01% |
455,574
+18,631
| +4% | +$2.06M |
|
952
Donaldson
DCI
$10.9B
| $56.6M | 0.01% |
757,730
+3,083
| +0.4% | +$210K |
|
953
Timken Company
TKR
$9.56B
| $56.5M | 0.01% |
646,463
+20,871
| +3% | +$1.72M |
|
954
Franklin Resources
BEN
$17.6B
| $56.4M | 0.01% |
2,007,205
+128,868
| +7% | +$3.55M |
|
955
Ionis Pharmaceuticals
IONS
$8.6B
| $56.4M | 0.01% |
1,301,368
+26,049
| +2% | +$1.24M |
|
956
FirstCash
FCFS
$8.85B
| $56.3M | 0.01% |
441,182
+5,481
| +1% | +$635K |
|
957
Valaris
VAL
$5.48B
| $56.2M | 0.01% |
747,231
+13,698
| +2% | +$918K |
|
958
Affirm
AFRM
$23.9B
| $56.2M | 0.01% |
1,507,017
+136,509
| +10% | +$5.45M |
|
959
Gentex
GNTX
$4.97B
| $56.1M | 0.01% |
1,552,305
+881
| +0.1% | +$30.5K |
|
960
ESAB
ESAB
$5.38B
| $56M | 0.01% |
506,850
+7,253
| +1% | +$677K |
|
961
Old Republic International
ORI
$10.5B
| $56M | 0.01% |
1,822,215
+5,111
| +0.3% | +$149K |
|
962
Patterson-UTI
PTEN
$3.98B
| $55.9M | 0.01% |
4,681,093
-103,844
| -2% | -$1.15M |
|
963
Virtus Investment Partners
VRTS
$1.06B
| $55.7M | 0.01% |
224,790
+128,709
| +134% | +$30.5M |
|
964
Royalty Pharma
RPRX
$25.9B
| $55.7M | 0.01% |
1,833,005
+62,017
| +4% | +$1.83M |
|
965
Rithm Capital
RITM
$5.52B
| $55.6M | 0.01% |
4,981,089
+127,521
| +3% | +$1.37M |
|
966
Knife River
KNF
$4.15B
| $55.6M | 0.01% |
685,582
+198,382
| +41% | +$13.9M |
|
|
MASI
967
DELISTED
Masimo
MASI
| $55.6M | 0.01% |
378,375
+10,334
| +3% | +$1.33M |
|
968
Element Solutions
ESI
$8.95B
| $55.5M | 0.01% |
2,221,250
+52,272
| +2% | +$1.22M |
|
969
Jazz Pharmaceuticals
JAZZ
$15.9B
| $55.4M | 0.01% |
459,944
-45,710
| -9% | -$5.6M |
|
|
WCC
970
WESCO International
WCC
$16.7B
| $55.3M | 0.01% |
322,715
+12,533
| +4% | +$2.07M |
|
971
United Bankshares
UBSI
$6.63B
| $55.2M | 0.01% |
1,541,474
+54,670
| +4% | +$1.93M |
|
972
H.B. Fuller
FUL
$2.97B
| $55.2M | 0.01% |
691,730
+22,862
| +3% | +$1.79M |
|
973
Aramark
ARMK
$15B
| $55.1M | 0.01% |
1,695,464
+21,247
| +1% | +$640K |
|
|
AZEK
974
DELISTED
The AZEK Co
AZEK
| $55.1M | 0.01% |
1,096,281
+4,105
| +0.4% | +$179K |
|
|
GMS
975
DELISTED
GMS Inc
GMS
| $54.9M | 0.01% |
564,114
+5,483
| +1% | +$480K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.